We are looking for children to join a CD clinical trial to help us discover more about treating moderate to severe ulcerative colitis. If you are looking for a potential new treatment option for moderate to severe ulcerative colitis or UC (including associated symptoms such as abdominal pain or cramping, inflammation of the bowel or intestine, diarrhea, frequent fevers and/or anemia), consider one of our medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children may be eligible to take part.

Your child may be eligible to take part in the medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Is your child currently experiencing Crohn’s disease flare-ups? Local Crohn’s disease clinical research study is testing a potential new medication to see if it may reduce diarrhea with blood and pus, weight loss, abdominal pain, frequent fevers, and/or liver disease associated with Crohn’s disease.
If you’re concerned about how Crohn’s disease affects your child’s life, find out more about the Crohn’s disease clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for 2 to 17 years old to join a CD trial to help us discover more about treating Crohn’s and ulcerative colitis. If you are looking for a potential new treatment option for Crohn’s and ulcerative colitis or Crohn’s and ulcerative colitis (including associated symptoms such as weight loss, loss of appetite, bloody stool, malnutrition and/or joint pain), consider one of our ICD and UC clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the ICD and UC clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing moderately to severely active ulcerative colitis flare-ups? Local CD research study is testing a potential new medication to see if it may reduce abdominal cramping, fever, rectal pain, malnutrition, and/or eye pain associated with moderately to severely active ulcerative colitis.
If you’re concerned about how moderately to severely active ulcerative colitis affects your child’s life, find out more about the CD research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

We are looking for young people 2 to 17 years old to join a Crohn’s disease research to help us discover more about treating moderate to severe Crohn’s disease. If you are looking for a potential new treatment option for moderate to severe Crohn’s disease or Crohn’s disease (including associated symptoms such as diarrhea with blood, fistula, cramps, frequent fevers and/or anemia), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the IBD clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing moderate to severe UC flare-ups? Local Crohn’s disease (CD) clinical research study is testing a potential new medication to see if it may reduce weight loss, joint pain, abdominal pain, chronic fatigue, and/or joint pain associated with moderate to severe UC.
If you’re concerned about how moderate to severe UC affects your child’s life, find out more about the Crohn’s disease (CD) clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

We are looking for children 2 to 17 years of age to join a clinical research to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or Crohn’s disease (including associated symptoms such as diarrhea with blood, growth failure, rectal pain, weight loss and/or anemia), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the IBD studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

Is your child currently experiencing moderately to severely active IBD flare-ups? Local Crohn’s disease trial is testing a potential new medication to see if it may reduce urgency to defecate, abdominal cramps, abdominal pain, chronic fatigue, and/or eye pain associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the Crohn’s disease trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

We are looking for teen to join a CD trial to help us discover more about treating Crohn’s and UC. If you are looking for a potential new treatment option for Crohn’s and UC or moderate to severe UC (including associated symptoms such as swollen joints, joint pain, constant need to poop, weight loss and/or canker sores), consider one of our Crohn’s disease (CD) clinical research. All eligible participants will receive no-cost study-related care and study medication. Your teen may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease flare-ups? Local Crohn’s disease (CD) research is testing a potential new medication to see if it may reduce painful joints, abdominal cramps, bloody stool, frequent fevers, and/or anemia associated with inflammatory bowel disease.
If you’re concerned about how inflammatory bowel disease affects your child’s life, find out more about the Crohn’s disease (CD) research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.